Tenax Therapeutics (TENX) Profit After Tax (2010 - 2026)
Tenax Therapeutics recorded quarterly Profit After Tax of -$15.7 million in Q1 2026, down 1.3% quarter-over-quarter from -$15.5 million in Q4 2025, and down 50.96% year-over-year from -$32.0 million in Q1 2025.
Tenax Therapeutics' Profit After Tax history runs 16 years deep, the most recent figure standing at -$15.7 million for Q1 2026.
- In Q1 2026, Profit After Tax fell 50.96% year-over-year to -$15.7 million; the TTM figure through Mar 2026 stood at -$57.8 million (down 138.69% YoY), while the FY2025 annual figure was -$52.6 million, down 198.86% from the prior year.
- Profit After Tax came in at -$15.7 million for Q1 2026 at Tenax Therapeutics, down from -$15.5 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $2.9 million in Q3 2022 to a low of -$15.8 million in Q3 2025.
- A 5-year average of -$5.8 million and a median of -$3.8 million in 2024 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax surged 104.13% in 2022 and slumped 578.07% in 2023, its largest moves.
- Tenax Therapeutics' Profit After Tax stood at $2.5 million in 2022, then plunged by 578.07% to -$12.2 million in 2023, then jumped by 48.3% to -$6.3 million in 2024, then sank by 146.02% to -$15.5 million in 2025, then fell by 1.3% to -$15.7 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered -$15.7 million, -$15.5 million, and -$15.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | -15.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.70 Mn |
| Dec 31, 2025 | -15.50 Mn |
| Sep 30, 2025 | -15.80 Mn |
| Jun 30, 2025 | -10.85 Mn |
| Mar 31, 2025 | -10.40 Mn |
| Dec 31, 2024 | -6.30 Mn |
| Sep 30, 2024 | -3.96 Mn |
| Jun 30, 2024 | -3.58 Mn |
| Mar 31, 2024 | -3.80 Mn |
| Dec 31, 2023 | -12.19 Mn |
| Sep 30, 2023 | 1.97 Mn |
| Jun 30, 2023 | -1.11 Mn |
| Mar 31, 2023 | -1.41 Mn |
| Dec 31, 2022 | 2.55 Mn |
| Sep 30, 2022 | 2.92 Mn |
| Jun 30, 2022 | -2.86 Mn |
| Mar 31, 2022 | -2.72 Mn |
| Dec 31, 2021 | -61.74 Mn |
| Sep 30, 2021 | 3.80 Mn |
| Jun 30, 2021 | -1.72 Mn |
| Mar 31, 2021 | -23.75 Mn |
| Dec 31, 2020 | -16.87 Mn |
| Sep 30, 2020 | -2.22 Mn |
| Jun 30, 2020 | -2.15 Mn |
| Mar 31, 2020 | -2.65 Mn |
| Dec 31, 2019 | -14.00 Mn |
| Sep 30, 2019 | 2.22 Mn |
| Jun 30, 2019 | 1.76 Mn |
| Mar 31, 2019 | 1.62 Mn |
| Dec 31, 2018 | -18.74 Mn |
| Sep 30, 2018 | 1.54 Mn |
| Jun 30, 2018 | 1.87 Mn |
| Mar 31, 2018 | 1.19 Mn |
| Dec 31, 2017 | -16.34 Mn |
| Sep 30, 2017 | 1.23 Mn |
| Jun 30, 2017 | 2.99 Mn |
| Mar 31, 2017 | 3.28 Mn |
| Dec 31, 2016 | -58.20 Mn |
| Sep 30, 2016 | 4.27 Mn |
| Jun 30, 2016 | 4.64 Mn |
| Mar 31, 2016 | -5.36 Mn |
| Dec 31, 2015 | -10.07 Mn |
| Sep 30, 2015 | -2.92 Mn |
| Jun 30, 2015 | -4.75 Mn |
| Apr 30, 2013 | -1.86 Mn |
| Jan 31, 2013 | -2.41 Mn |
| Oct 31, 2012 | -1.56 Mn |
| Jul 31, 2012 | -3.59 Mn |
| Apr 30, 2012 | -2.61 Mn |
| Jan 31, 2012 | -7.30 Mn |
| Oct 31, 2011 | -2.93 Mn |
| Jul 31, 2011 | -2.87 Mn |
| Apr 30, 2011 | 2.85 Mn |
| Jan 31, 2011 | 2.54 Mn |
| Oct 31, 2010 | 2.05 Mn |
| Jul 31, 2010 | 3.00 Mn |